GL1X · GenesisL1 explorer

Research workbench

HIV env BG505 nfl td+ in complex with antibody E70 fragment antigen binding

Analyse HIV env BG505 nfl td+ in complex with antibody E70 fragment antigen binding in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6P62
Type
protein
Length
2,334 residues
Chains
9
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
HIV-1 env BG505 nfl td+; Rabbit monoclonal antibody E70 heavy chain fragment antigen…
Ligands
NAG, MAN, BMA
Pockets
20 · best druggability 0.83

Structure

electron microscopy · 3 distinct chains · 18% helix, 37% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, EHIV-1 env BG505 nfl td+protein55124% helix, 34% strand—
H, C, FRabbit monoclonal antibody E70 heavy chain fragment antigen bindingprotein1195% helix, 50% strand—
L, D, GRabbit monoclonal antibody E70 kappa chainprotein1083% helix, 38% strand—

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 63 copies · chains A, B, E
  • MAN · alpha-D-mannopyranose · sugar · 15 copies · chains H, A, L, C, B, D, F, E, G
  • BMA · beta-D-mannopyranose · sugar · 6 copies

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 14 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14120.830.9148empty
25400.760.8370NAG
33070.740.8649NAG
43930.730.8459NAG
5800.680.9324empty

Interfaces

12 interfaces between chains.

  • B–E · 1399 Ų buried · 16 hydrogen bonds · protein-protein
  • A–E · 1398 Ų buried · 16 hydrogen bonds · protein-protein
  • A–B · 1396 Ų buried · 16 hydrogen bonds · protein-protein
  • H–L · 966 Ų buried · 7 hydrogen bonds · protein-protein
  • F–G · 964 Ų buried · 8 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 45 glycan, 39 disulfide (N-glycosylation, disulfide).

Compared structures

  • 6P62 · HIV Env BG505 NFL TD+ in complex with antibody E70 fragment antigen binding · the same entry in another collection · chain D against D, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.